Genetically engineered bacterium for producing gibberellin GA3 as well as construction method and application thereof
By introducing multi-copy tHMGR gene using CRISPR-Cas9 gene editing technology in Fujikura gibberellia, the problem of insufficient synthesis ability in gibberellin GA3 production process was solved, and the production of gibberellin GA3 was significantly improved and the fermentation efficiency was improved. .
Patent Information
- Application Number
- CN202411039223.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-31
- Publication Date
- 2024-11-12
AI Technical Summary
In the existing gibberellin GA3 production process, the synthesis capacity of Fujikura gibberellin is weak, resulting in high production costs and long fermentation cycles, limiting the industrial application of gibberellin GA3.
CRISPR-Cas9 gene editing technology replaces the bicavirin-encoded gene in Gibberia Fujikura, and introduces multiple copies of the gene tHMGR of methglutarate monoacyl Coenzyme A reductase catalytic region to increase the supply of precursors for gibberellin GA3 to increase production.
Through the construction of genetically engineered bacteria, the yield of gibberellin GA3 increased by 40.33%, from 1.81g/L to 2.54g/L, reducing the production of by-products and improving the fermentation efficiency.
Smart Images

Figure CN118931936A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of metabolic engineering, and specifically relates to a genetic engineering bacterium for producing gibberellin GA3 and a construction method and application thereof. Background Art
[0002] Gibberellic acid GA3 is a tetracyclic diterpenoid compound with a molecular formula of C 19 H 22 O6 is a white crystalline powder. Gibberellins are a type of broad-spectrum plant growth hormone with excellent performance. They can promote plant cell division and extension, accelerate crop growth and development, and on this basis improve crop quality and increase yield; they can reduce crop organ shedding and increase fruit setting rate; they can break dormancy and promote crop germination; and they are low-toxic to humans and animals, and are low-toxic plant growth regulators. The mature fruits are safer to eat. Nowadays, gibberellins have been widely used in the cultivation of vegetables, fruits, wheat, cotton and other crops.
[0003] Due to the complex structure of gibberellin GA3, the chemical synthesis of GA3 has many reaction steps, low conversion rate, and by-products are easily produced during the reaction, which is difficult to separate and purify, making it difficult to use for industrialization. The current mainstream gibberellin GA3 production process is to use Fujikura Gibberella as the production strain for liquid deep fermentation. The fermentation conditions are stable and controllable, the product separation and purification process is mature, and the fermentation residue is easy to degrade and treat. However, due to the low natural synthesis ability of the production strain, long fermentation cycle, and high production cost, the industrial development of gibberellin GA3 is currently limited, so genetically engineered bacteria are introduced as a new way to solve the problems in the traditional gibberellin production method. Genetically engineered bacteria can achieve efficient and low-cost gibberellin production by transforming the gibberellin biosynthesis pathway or introducing related metabolic pathways. Summary of the invention
[0004] In order to solve the problem of weak gibberellin GA3 synthesis ability of gibberellin in the prior art, the present invention provides a genetically engineered bacterium of Fujikura gibberellin with high gibberellin GA3 production, a construction method and an application thereof.
[0005] The technical solution adopted by the present invention is: a method for constructing a genetically engineered bacterium for producing gibberellin GA3, comprising: using CRISPR-Cas9 gene editing technology to replace the original bicavillin encoding gene on the genome of the starting strain Gibberella fujikura with a single copy or multiple copies of the meglutaryl-CoA reductase catalytic region gene tHMGR, so as to obtain a genetically engineered bacterium for producing gibberellin GA3.
[0006] At present, the industrial production of GA3 is carried out by submerged liquid fermentation using Fusarium fujikura as the production strain. Figure 1In Gibberella fujikura, the synthesis site of GA3 is in the cytoplasm, starting from acetyl-coenzyme A (Acetyl-CoA) synthesized by the TCA cycle, and producing isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP) through the mevalonate (MVA) pathway. IPP and DMAPP can be condensed into geranyl diphosphate (GPP), farnesyl diphosphate (FPP), geranyl diphosphate (GGPP) and geranyl farnesyl diphosphate (GFPP) under the catalysis of enzymes, and then further catalyzed by a variety of oxidases and cyclases to form the structural skeleton of gibberellin GA3. Finally, the side chains on the structural skeleton of gibberellin GA3 may undergo a variety of modification reactions, such as carboxylation, decarboxylation, dehydration, etc., to form the final gibberellin GA3.
[0007] Among them, the MVA pathway is an important precursor synthesis pathway, which involves a biosynthetic process starting from acetyl-CoA, and ultimately produces two precursor substances, isoprene dicarboxylic acid (IPP) and diisoprene dicarboxylic acid (DMAPP). The MVA pathway consists of 9 enzymatic reactions, among which the enzymatic reactions involving 3-hydroxy-3-methylglutaryl-CoA reductase HMGR, hydroxymethylglutaryl-CoA synthetase ERG13 and diphosphate isoglutaryl δ-isomerase IDI are rate-limiting steps. As the key rate-limiting enzyme in the MVA pathway, meglutaryl-CoA reductase can convert acetyl-CoA into terpenoid skeleton precursor compounds. Overexpression of this gene can increase the precursor pool for the synthesis of terpenoid compounds. Screening for effective heterologous tHMGR can overcome low activity and possible negative feedback regulation. In addition, studies have shown that the HMGR gene contains an anchor transmembrane domain and a catalytic domain. Truncating the transmembrane domain can effectively increase its catalytic activity. Therefore, the present invention improves the expression of meglutaryl-CoA reductase by overexpressing truncated HMGR (tHMGR) in the chassis strain Fusariumfujikuroi to obtain the Fusariumfujikuroi with high gibberellin GA3 production.
[0008] The present invention uses CRISPR-Cas9 gene editing technology, guides Cas9 protein to accurately cut the metabolic byproduct bikaverin encoding gene target bik3 in the chassis strain Fujikura Gibberella through the positioning of sgRNA, creates a double-strand break gap on the genome, and introduces the encoding gene of the catalytic region tHMGR of the meglutaryl-CoA reductase from Yarrowia lipolytica during repair, and regulates the expression of the gene tHMGR through the endogenous promoter Pdes of Fujikura Gibberella and the terminator Ttef1 from Aspergillus nidulans; and further continuously integrates multiple copies of tHMGR at the bik1 and bik2 gene sites respectively. The constructed genetically engineered bacteria improves the supply of precursors IPP and DMAPP in the process of producing gibberellin GA3, wherein the genetically engineered bacteria with three copies of tHMGR have a GA3 yield of 2.54 g / L after 168h fermentation in the fermentation medium, which is 40.33% higher than the GA3 yield of the starting strain.
[0009] Preferably, the starting strain is Fusariumfujikuroi CCTCC NO:M2019378.
[0010] Preferably, the bikaverin encoding gene is selected from at least one of bik1, bik2, and bik3. It is understandable that the gene expression cassette containing the megaglutaryl-CoA reductase catalytic region gene tHMGR can replace any one of bik1, bik2, and bik3 in the form of a single copy; similarly, the eukaryotic expression cassette containing the gene tHMGR can also replace any two of bik1, bik2, and bik3 in the form of multiple copies, such as replacing bik1 and bik3 with eukaryotic expression cassettes containing the gene tHMGR, respectively, so that there are double copies of tHMGR on the bikaverin encoding gene cluster; or, the bik1, bik2, and bik3 sites are all replaced with eukaryotic expression cassettes containing the gene tHMGR, so that there are multiple copies of tHMGR on the bikaverin encoding gene cluster.
[0011] Preferably, the meglutaryl-CoA reductase catalytic region gene tHMGR is derived from at least one of Gibberella fujikura, Yarrowia lipolytica, Saccharomyces cerevisiae, and Pichia pastoris, more preferably Yarrowia lipolytica. Among them, the nucleotide sequence of the gene tHMGR derived from Gibberella fujikura is preferably as shown in SEQ ID NO.3, the nucleotide sequence of the gene tHMGR derived from Saccharomyces cerevisiae is as shown in SEQ ID NO.4, and the nucleotide sequence of the gene tHMGR derived from Pichia pastoris is as shown in SEQ ID NO.6.
[0012] Preferably, the nucleotide sequence of the meglutaryl-CoA reductase catalytic region gene tHMGR is as shown in SEQ ID NO.5.
[0013] Preferably, the meglutaryl-CoA reductase catalytic region gene tHMGR is derived from Yarrowia lipolytica, and its nucleotide sequence is preferably as shown in SEQ ID NO.5
[0014] It is understandable that the gene tHMGR is constructed into a eukaryotic expression cassette, and the eukaryotic expression cassette contains a promoter and a terminator at its upstream and downstream, respectively, and the expression of the gene tHMGR is regulated by the promoter and the terminator.
[0015] Preferably, the expression of the meglutaryl-CoA reductase catalytic region gene tHMGR is regulated by the endogenous promoter Pdes of Fusarium fujikuroi. The nucleotide sequence of the Pdes promoter amplified using the genome of Fusarium fujikuroi CCTCC NO: M 2019378 as a template is preferably as shown in SEQ ID NO.1.
[0016] Preferably, the expression of the meglutaryl-CoA reductase catalytic region gene tHMGR is regulated by the terminator Ttef1 from Aspergillus nidulans. The nucleotide sequence of the Ttef1 terminator amplified using the Aspergillus nidulans genome as a template is preferably as shown in SEQ ID NO.2.
[0017] Preferably, the method comprises: using CRISPR-Cas9 gene editing technology to replace the original bikaverin encoding genes bik1, bik2, and bik3 on the genome of the starting strain Fusariumfujikuroi CCTCC NO:M 2019378 with the meglutaryl-CoA reductase catalytic region gene tHMGR from Yarrowia lipolytica, respectively, to obtain a genetically engineered bacterium for producing gibberellin GA3; the expression of the meglutaryl-CoA reductase catalytic region gene tHMGR is regulated by the endogenous promoter Pdes of Fusariumfujikuroi and the terminator Ttef1 from Aspergillus nidulans.
[0018] Preferably, the method comprises:
[0019] Constructing an expression vector targeting the bicavirin encoding gene with a eukaryotic expression cassette: the eukaryotic expression cassette contains the endogenous promoter Pdes of Gibberella fujikura, the gene tHMGR, and the terminator Ttef1 from Aspergillus nidulans;
[0020] The obtained expression vector was introduced into Gibberella fujikura through PEG-mediated protoplast transformation technology;
[0021] The eukaryotic expression box is homologously recombined to at least one site among bik1, bik2 and bik3 to obtain a genetically engineered bacterium that produces gibberellin GA3.
[0022] The present invention also provides a genetic engineering bacterium for producing gibberellin GA3 constructed by the method.
[0023] The present invention also provides the application of the genetically engineered bacteria in the fermentation production of gibberellin GA3, characterized in that the application method is: inoculating the Fujikura Gibberella into a fermentation medium, and fermenting and culturing for 150 to 200 hours at 25 to 30° C. and 200 to 300 rpm to obtain gibberellin GA3.
[0024] Preferably, the fermentation medium is composed of: 70-90 g / L corn starch, 70-90 g / L rice flour, 10-30 g / L soybean flour, 10-30 g / L peanut flour, 0.5-1.5 g / L potassium sulfate, 0.5-1.5 g / L potassium dihydrogen phosphate, the solvent is water, and the pH is natural.
[0025] The beneficial effects of the present invention are as follows: the present invention uses Gibberella fujikura as a starting strain and provides a method for constructing a genetically engineered bacterium for producing gibberellin GA3. The constructed genetically engineered bacterium reduces the production of by-products and improves the supply capacity of precursors IPP and DMAPP in the GA3 synthesis process. Compared with the starting strain, the fermentation production of GA3 can be more effectively carried out, and the output is increased from 1.81 g / L to 2.54 g / L, which provides a feasible route for the construction of an engineering strain for producing gibberellin. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 This is the node diagram of the GA3 synthesis path.
[0027] Figure 2 The plasmid pFC332-Ffcas9-Δbik3::Pdes-gene map in Example 1
[0028] Figure 3 The map of plasmid pFC332-Ffcas9-Δbik1::Pdes-YL.tHMGR in Example 2
[0029] Figure 4 The map of plasmid pFC332-Ffcas9-Δbik2::Pdes-YL.tHMGR in Example 2
[0030] Figure 5 This is a diagram for identifying the strains in Examples 1 and 2. DETAILED DESCRIPTION
[0031] The following is an explanation of the embodiments of the present invention by specific specific examples, and those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification. The present invention can also be implemented or applied by other different specific embodiments, and the details in this specification can also be modified or changed in various ways based on different viewpoints and applications without departing from the spirit of the present invention. It should be noted that, in the absence of conflict, the features in the following embodiments and embodiments can be combined with each other. In the embodiments of the present invention, the methods used are all conventional methods unless otherwise specified, and the reagents used can be obtained from commercial sources.
[0032] Example 1: Screening of multi-source tHMGR genes and construction of overexpression strains
[0033] (1) Construction of multi-source tHMGR gene overexpression vector
[0034] The mevalonate-CoA reductase encoded by the HMGR gene plays the role of the rate-limiting enzyme in the mevalonate pathway. The CRISPR-Cas9 system was used to knock out the bik3 gene in Gibberella fujikura and overexpress the tHMGR gene.
[0035] First, sgRNA-Δbik3-1 fragment was amplified by PCR using primers 1 and 2, with the sgRNA expression frame as a template. The PCR reaction conditions were as follows: 98°C for 5 min; 98°C for 30 s, 60°C for 30 s, 72°C for 30 s, repeated for 32 cycles; 72°C for 5 min. The PCR product was detected by 1% agarose gel electrophoresis and the fragment was purified. The sgRNA-Δbik3-2 fragment was amplified using primers 3 and 4 in the same way. The PCR reaction conditions were as follows: 98°C for 5 min; 98°C for 30 s, 60°C for 30 s, 72°C for 30 s, repeated for 32 cycles; 72°C for 5 min. The PCR product was detected by 1% agarose gel electrophoresis and the fragment was purified. The two purified DNA fragments were subjected to fusion PCR using primers 1 and 4. The PCR reaction conditions were as follows: 98°C for 5 min; 98°C for 30 s, 60°C for 30 s, 72°C for 30 s, repeated for 32 cycles; 72°C for another 5 min. The PCR products were detected by 1% agarose gel electrophoresis and the fragments were purified.
[0036] Primers 5 and 6 were used to amplify the upstream homologous fragment of the bik3 gene using the genome of Fusariumfujikuroi CCTCC NO:M 2019378 as a template. The PCR reaction conditions were as follows: 98℃5min; 98℃30s, 60℃30s, 72℃30s, repeated 32 cycles; 72℃ continued for 5min. The PCR product was detected by 1% agarose gel electrophoresis and the fragment was purified. In the same way, primers 7 and 8 were used to amplify the downstream homologous fragment of the bik3 gene. The PCR reaction conditions were as follows: 98℃5min; 98℃30s, 60℃30s, 72℃30s, repeated 32 cycles; 72℃ continued for 5min. The PCR product was detected by 1% agarose gel electrophoresis and the fragment was purified.
[0037] Using the pFC332-Ffcas9 vector as a template, the one-step cloning kit ClonExpress IIOne StepCloning Kit (purchased from Nanjing Novogene) was used to connect and construct the pFC332-Ffcas9-Δbik3 plasmid vector capable of expressing the target gene bik3. The ligation product was transformed into the E. coli DH5α recipient bacteria, spread on an LB solid plate containing a final concentration of 100 mg / L ampicillin resistance, and cultured at 37°C for 12 hours. A single colony was picked and placed in an LB liquid medium containing a final concentration of 100 mg / L ampicillin resistance, cultured at 37°C for 12 hours, and the bacterial cells were collected to extract the plasmid and the plasmid was linearized using the rapid endonuclease PacⅠ (purchased from Beijing Langbolide).
[0038] The Pdes promoter sequence (its nucleotide sequence is shown in SEQ ID NO.1) was amplified by PCR using primers 9 and 10 with the genome of Fusariumfujikuroi CCTCC NO:M2019378 as a template, and the Ttef1 terminator sequence (its nucleotide sequence is shown in SEQ ID NO.2) was amplified using primers 11 and 12 with the genome of Aspergillus nidulans as a template. The PCR reaction conditions were as follows: 98°C for 5 min; 98°C for 30 s, 60°C for 30 s, 72°C for 30 s, repeated for 32 cycles; 72°C for 5 min. The PCR product was detected by 1% agarose gel electrophoresis and the fragment was purified. The Pdes promoter fragment and the Ttef1 terminator were connected to the plasmid pFC332-Ffcas9-Δbik3 treated with the rapid endonuclease PacⅠ by one-step cloning kit ClonExpress IIOne Step Cloning Kit (purchased from Nanjing Novogene) to construct an expression vector containing the gene expression cassette of the Pdes promoter fragment and the Ttef1 terminator fragment. The ligation product was transformed into the E.coliDH5α recipient bacteria, spread on the LB solid plate containing the final concentration of 100 mg / L ampicillin resistance, cultured at 37℃ for 12h, picked a single colony to the LB liquid medium containing the final concentration of 100 mg / L ampicillin resistance, cultured at 37℃ for 12h, collected the bacteria to extract the plasmid, and used the rapid endonuclease PacⅠ (purchased from Beijing Langbolid) to linearize the plasmid.
[0039] In order to obtain highly efficiently expressed megaloglutaryl-CoA reductase, the truncated tHMGR from Gibberella fujikura (whose nucleotide sequence is shown in SEQ ID NO.3) is overexpressed, or the tHMGR gene from Saccharomyces cerevisiae is heterologously expressed (whose nucleotide sequence is shown in SEQ ID NO.4), or the tHMGR gene from Yarrowia lipolytica is heterologously expressed (whose nucleotide sequence is shown in SEQ ID NO.5), or the tHMGR gene from Pichia pastoris is heterologously expressed (whose nucleotide sequence is shown in SEQ ID NO.6), and the specific method is as follows.
[0040] The catalytic region sequence of meglutaryl-CoA reductase was amplified by PCR using primers 13 and 14, primers 15 and 16, primers 17 and 18, primers 19 and 20, respectively, with the genome of Fusariumfujikuroi CCTCC NO:M 2019378, Saccharomyces cerevisiae, Yarrowia lipolytica and Pichia pastoris as templates. The PCR reaction conditions were as follows: 98℃5min; 98℃30s, 60℃30s, 72℃60s, repeated 32 cycles; 72℃ for 5min. The PCR products were detected by 1% agarose gel electrophoresis and the fragments were purified. The four DNA fragments were ligated into the plasmid pFC332-Ffcas9-Δbik3-Pdes-Ttef1 linearized by rapid endonuclease PacⅠ using ClonExpress IIOne Step Cloning Kit (purchased from Nanjing Novozyme). The ligation product was transformed into the E. coli DH5α recipient bacteria, spread on an LB solid plate containing a final concentration of 100 mg / L ampicillin resistance, and cultured at 37°C for 12 hours. A single colony was picked and transferred to an LB liquid medium containing a final concentration of 100 mg / L ampicillin resistance, and cultured at 37°C for 12 hours. The bacterial cells were collected and the plasmids were extracted to obtain:
[0041] Overexpression of Fusarium tHMGR plasmid pFC332-Ffcas9-Δbik3::Pdes-FF.tHMGR,
[0042] Overexpression of Saccharomyces cerevisiae tHMGR plasmid pFC332-Ffcas9-Δbik3::Pdes-SC.tHMGR,
[0043] Overexpression of Yarrowia lipolytica tHMGR plasmid pFC332-Ffcas9-Δbik3::Pdes-YL.tHMGR,
[0044] Overexpression of Pichia pastoris tHMGR plasmid pFC332-Ffcas9-Δbik3::Pdes-PP.tHMGR.
[0045] (2) Protoplast transformation of Gibberella fujikura and identification of transformants
[0046] Fusariumfujikuroi CCTCC NO:M 2019378 preserved in a glycerol tube was inoculated into YPD medium and cultured at 28°C and 220rpm for 2 days. After the culture, 1g of mycelium was collected using a Buchner funnel and enzymatically hydrolyzed for 3h using an enzyme solution (Yatalase 1%, snail enzyme 0.5%, and lysozyme 0.5%) at 120rpm and 30°C. The protoplast fluid was filtered, and the filtrate was centrifuged at 4°C and 2700rpm for 10min, the supernatant was discarded, and the filtrate was washed once with STC Buffer and centrifuged again at 4°C and 2700rpm for 10min, and the supernatant was discarded. The protoplasts were resuspended with 1mL STC Buffer. Take 160 μL of protoplast resuspension, 100 μL of tHMGR gene overexpression plasmid and 60 μL of precooled PEG solution in a 2 mL EP tube and mix them evenly. After ice bathing for 30 minutes, add precooled PEG solution to the 2 mL mark, mix evenly, place at room temperature for 25 minutes, mix evenly with 6 mL of CD soft agar medium (containing hygromycin with a final concentration of 100 mg / L), and pour on CD hard agar medium (containing hygromycin with a final concentration of 100 mg / L), culture at 28°C for 5 to 6 days, pick a single colony to extract the genome, and perform PCR with primers 21 and 22 to confirm the insertion of the tHMGR expression frame. The strains constructed in this way are recorded as FF1 (overexpressing Gibberella fujikura tHMGR), FF2 (overexpressing Saccharomyces cerevisiae tHMGR), FF3 (overexpressing Yarrowia lipolytica tHMGR), and FF4 (overexpressing Pichia pastoris tHMGR).
[0047] (3) Plasmid recycling method
[0048] The strains FF1, FF2, FF3, and FF4 were cultured in YPD liquid medium containing hygromycin at 28°C for 2 days to remove the pFC332 plasmid and then recycle the hygromycin resistance tag.
[0049] Table 1. Primer sequences
[0050] Primers sequence Primer 1 agctgtttccgctgagggtttaatcacatacgaccaaaggtagtg Primer 2 cgttgttctccttgatgactcatacaacagcggggattcg Primer 3 agtcatcaaggagaacaacggttttagagctagaaatagcaag Primer 4 agaaactcgacatcagctataaaaaaaagcaccgactcggt Primer 5 ccgagtcggtgcttttttttggtgatagtgagatggagtaga Primer 6 tctattaatcccttaattaagttgggcgatgtgatttgtga Primer 7 acatcgcccaacttaattaagggattaatagatttagttacgc Primer 8 ctgtctcggctgaggtcttacgccatctcgcataatcgca Primer 9 catctcactatcaccttaatgtaaacagtctcataaatacggttg Primer 10 tcgaatgtccgcttaattaacgtgacaagaatgataacgg Primer 11 attcttgtcacgttaattaagcggacattcgatttatgcc Primer 12 tctgtagagaggccattttagtattggggatgaattttgtatg Primer 13 atcattcttgtcacgttaatatggccaagtccaacaaccg Primer 14 ataaatcgaatgtccgcttactatcgctttgacctctgaatag Primer 15 atcattcttgtcacgttaatatggctgcagaccaattggt Primer 16 ataaatcgaatgtccgcttattaggatttaatgcaggtgacg Primer 17 atcattcttgtcacgttaatatgacccagtctgtgaaggt Primer 18 taaatcgaatgtccgcttactatgaccgtatgcaaatattc Primer 19 atcattcttgtcacgttaataatgcttactgggttgtccaa Primer 20 ataaatcgaatgtccgcttatcaagatttaatgcaaatct Primer 21 tcggtttacgggctttcaga Primer 22 caacccctggaatgtgtcat
[0051] Example 2: Construction of tHMGR gene multi-copy expression strain
[0052] (1) Construction of tHMGR overexpression vector from Yarrowia lipolytica
[0053] First, sgRNA-Δbik1-1 fragment was amplified by PCR using primers 23 and 24, with the sgRNA expression frame as a template. The PCR reaction conditions were as follows: 98°C for 5 min; 98°C for 30 s, 60°C for 30 s, 72°C for 30 s, repeated for 32 cycles; 72°C for 5 min. The PCR product was detected by 1% agarose gel electrophoresis and the fragment was purified. In the same way, primers 25 and 26 were used to amplify the sgRNA-Δbik1-2 fragment. The PCR reaction conditions were as follows: 98°C for 5 min; 98°C for 30 s, 60°C for 30 s, 72°C for 30 s, repeated for 32 cycles; 72°C for 5 min. The PCR product was detected by 1% agarose gel electrophoresis and the fragment was purified. The two purified DNA fragments were subjected to fusion PCR using primers 23 and 26. The PCR reaction conditions were as follows: 98°C for 5 min; 98°C for 30 s, 60°C for 30 s, 72°C for 30 s, repeated for 32 cycles; 72°C for another 5 min. The PCR products were detected by 1% agarose gel electrophoresis and the fragments were purified.
[0054] Primers 27 and 28 were used to amplify the upstream homologous fragment of the bik1 gene using the genome of Fusariumfujikuroi CCTCC NO:M 2019378 as a template. The PCR reaction conditions were as follows: 98℃5min; 98℃30s, 60℃30s, 72℃30s, repeated 32 cycles; 72℃ continued for 5min. The PCR product was detected by 1% agarose gel electrophoresis and the fragment was purified. In the same way, primers 29 and 30 were used to amplify the downstream homologous fragment of the bik1 gene. The PCR reaction conditions were as follows: 98℃5min; 98℃30s, 60℃30s, 72℃30s, repeated 32 cycles; 72℃ continued for 5min. The PCR product was detected by 1% agarose gel electrophoresis and the fragment was purified. Using the pFC332-Ffcas9 vector as a template, the pFC332-Ffcas9-Δbik1 plasmid vector capable of expressing the target gene bik1 was constructed by connecting with a one-step cloning kit ClonExpress IIOne Step Cloning Kit (purchased from Nanjing Novogene). In the same way, primers 31 and 32, primers 33 and 34, primers 35 and 36, primers 37 and 38 were used to construct the pFC332-Ffcas9-Δbik2 plasmid vector capable of expressing the target gene bik2. The ligation product was transformed into E. coli DH5α recipient bacteria, spread on LB solid plates containing ampicillin resistance at a final concentration of 100 mg / L, cultured at 37°C for 12 h, picked up single colonies and transferred to LB liquid culture medium containing ampicillin resistance at a final concentration of 100 mg / L, cultured at 37°C for 12 h, collected the cells to extract the plasmid, and linearized the plasmid using the rapid endonuclease PacⅠ.
[0055] The Pdes promoter fragment and the Ttef1 terminator were connected to the plasmids pFC332-Ffcas9-Δbik1 and pFC332-Ffcas9-Δbik2 treated with the rapid endonuclease PacⅠ by one-step cloning kit ClonExpress IIOne Step Cloning Kit (purchased from Nanjing Novogene), and the expression vector containing the gene expression cassette of the Pdes promoter fragment and the Ttef1 terminator fragment was constructed. The ligation product was transformed into the E.coli DH5α recipient bacteria, coated on the LB solid plate containing the final concentration of 100 mg / L ampicillin resistance, and cultured at 37℃ for 12h. Then, a single colony was picked and placed in the LB liquid medium containing the final concentration of 100 mg / L ampicillin resistance, cultured at 37℃ for 12h, and the bacterial cells were collected to extract the plasmid and the plasmid was linearized using the rapid endonuclease PacⅠ.
[0056] Subsequently, the YL.tHMGR fragment was ligated into the plasmid pFC332-Ffcas9-Δbik1-Pdes-Ttef1 and plasmid pFC332-Ffcas9-Δbik2-Pdes-Ttef1 linearized by rapid endonuclease PacⅠ using the one-step cloning kit ClonExpress IIOne Step Cloning Kit (purchased from Nanjing Novozymes). The ligation product was transformed into the E. coli DH5α recipient bacteria, spread on an LB solid plate containing ampicillin resistance at a final concentration of 100 mg / L, and cultured at 37°C for 12 h. Then, a single colony was picked and transferred to an LB liquid culture medium containing ampicillin resistance at a final concentration of 100 mg / L, and cultured at 37°C for 12 h. The bacteria were collected and the plasmids were extracted to obtain the Yarrowia lipolytica tHMGR overexpression plasmids pFC332-Ffcas9-Δbik1::Pdes-YL.tHMGR and pFC332-Ffcas9-Δbik2::Pdes-YL.tHMGR, respectively.
[0057] (2) Protoplast transformation of Gibberella fujikura and identification of transformants
[0058] The plasmid pFC332-Ffcas9-Δbik1::YL.tHMGR was transformed into the protoplasts of Fusarium fujikura FF3. The transformed bacterial solution was cultured on a CD plate containing hygromycin at a final concentration of 100 mg / L at 28°C for 5 to 6 days, and a single colony was picked to extract the genome. PCR was performed with primers 39 and 40 to confirm the insertion of the tHMGR expression frame. The strain that passed this confirmation was cultured at 28°C in a YPD liquid medium containing hygromycin for 2 days to remove the pFC332-Ffcas9 plasmid, and the YL.tHMGR double copy strain FF5 was constructed.
[0059] The plasmid pFC332-Ffcas9-Δbik2::Pdes-YL.tHMGR was transformed into strain FF5 in the same manner, and PCR was performed with primers 41 and 42 to confirm the insertion of the tHMGR expression cassette, thereby constructing the YL.tHMGR three-copy strain FF6.
[0060] Table 2 Primer sequences
[0061] Primer 23 gtttccgctgagggtttaatcacatacgaccaaaggtagtg Primer 24 cgtggggagtttaactacggtacatacaacagcggggattcg Primer 25 taccgtagtaaactcccacggttttagagctagaaatagcaag Primer 26 cttgaggcttaattcctagaaaaaaaaagcaccgactcggt Primer 27 ccgagtcggtgctttttttttctaggaattaagcctcaagg Primer 28 tcaacttccttgttaattaacgtgaaagaatggcaaaaataat Primer 29 cattctttcacgttaattaacaaggaagttgaagcagcaaa Primer 30 ctgtctcggctgaggtcttaattggatatcgtctgtaggttt Primer 31 tgtttccgctgagggtttaatcacatacgaccaaaggtagtg Primer 32 cggtgaacgcttcgccgtctcatacaacagcggggattcg Primer 33 agacggcgaagcgttcaccggttttagagctagaaatagcaag Primer 34 gtcacccctggaggtcttagaaaaaaaagcaccgactcggt Primer 35 ccgagtcggtgctttttttttctaagacctccaggggtgac Primer 36 agagaggccattttaattaaggtgatagtgagatggagtaga Primer 37 ctcactatcaccttaattaaaatggcctctctacagaacattt Primer 38 ctgtctcggctgaggtcttatatagcggctaattacgccacg Primer 39 acatgacaattgctccggtc Primer 40 atcgattaagctccctcgga Primer 41 aatgtccgtagtggcttgca Primer 42 gaatgtcaagacgaggaaga
[0062] Example 3: Shake flask fermentation of engineered strains
[0063] The engineered strains and the initial strain constructed in Examples 1 and 2 were respectively spread on PDA plates for activation, cultured at 28° C. for 3 days, and inoculated into 25 mL of seed culture medium, respectively. After cultured at 28° C. and 250 rpm for 48 h, the seed solution was inoculated into 40 mL of fermentation medium at a volume ratio of 10% (V / V), and cultured at 28° C. and 250 rpm for 7 days.
[0064] Seed culture medium composition: corn starch 20g / L, sucrose 20g / L, peanut powder 20g / L, soybean powder 20g / L, potassium dihydrogen phosphate 1.0g / L, magnesium sulfate 1.0g / L, the solvent is tap water, pH is natural, and sterilized at 115℃ for 30min.
[0065] The fermentation medium composition: corn starch 80g / L, rice flour 80g / L, soybean flour 5g / L, peanut flour 5g / L, potassium sulfate 0.5g / L, potassium dihydrogen phosphate 0.5g / L, the solvent is tap water, pH is natural, and sterilized at 115°C for 30min.
[0066] After 168 h of shake flask fermentation of the engineered strain, 2 mL of fermentation broth was centrifuged at 12000 rpm for 5 minutes in a centrifuge tube. The supernatant was diluted 50 times and filtered once with a 0.22 μm filter membrane for HPLC detection of gibberellin GA3.
[0067] HPLC detection instrument: Agilent LC1260, using Welchrom C18 4.6*150mm*5um column. Mobile phase: 40% methanol + 0.03% phosphoric acid. Flow rate: 1mL / min. Detection wavelength: 210nm. Injection volume: 10μL. GA3 retention time: about 7.5min.
[0068] The GA3 production by shake flask fermentation of the metabolically modified strains is shown in Table 3.
[0069] Table 3 Fermentation results of different genotype engineering strains
[0070] strains genotype <![CDATA[GA3 production (g / L)]]> FF1 F.fujikuroi-Δbik3::Pdes-FF.tHMGR 2.21 FF2 F.fujikuroi-Δbik3::Pdes-SC.tHMGR 2.19 FF3 F.fujikuroi-Δbik3::Pdes-YL.tHMGR 2.29 FF4 F.fujikuroi-Δbik3::Pdes-PP.tHMGR 1.93 FF5 FF3-Δbik3Δbik1::Pdes-YL.tHMGR 2.36 FF6 FF5-Δbik3Δbik1Δbik2::Pdes-YL.tHMGR 2.54
[0071] According to Table 3, the expression of multiple copies of the meglutaryl-CoA reductase gene can improve the ability of the strain to produce GA3 by fermentation. The tHMGR three-copy strain FF6 after metabolic engineering has the highest yield, reaching 2.54 g / L, which is 40.33% higher than the starting strain.
[0072] The embodiments described above are merely descriptions of preferred implementations of the present invention and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope of the present invention.
Claims
1. A method for constructing a genetically engineered bacterium for producing gibberellin GA3, characterized in that: include: Using CRISPR-Cas9 gene editing technology, the original picaverin encoding gene in the genome of the starting strain Gibberellic acid fungus was replaced with a single copy or multiple copies of the meglutaryl-CoA reductase catalytic region gene tHMGR to obtain a genetically engineered bacterium that produces gibberellin GA3.
2. The method according to claim 1, characterized in that The starting strain is Fusariumfujikuroi CCTCC NO:M 2019378.
3. The method according to claim 1, characterized in that The bicavirine encoding gene is selected from at least one of bik1, bik2, and bik3.
4. The method according to claim 1, characterized in that The meglutaryl-CoA reductase catalytic region gene tHMGR is derived from at least one of Gibberella fujikura, Yarrowia lipolytica, Saccharomyces cerevisiae and Pichia pastoris.
5. The method according to claim 1, characterized in that The nucleotide sequence of the meglutaryl-CoA reductase catalytic region gene tHMGR is shown in SEQ ID NO.
5.
6. The method according to claim 1, characterized in that The expression of the meglutaryl-CoA reductase catalytic region gene tHMGR is regulated by the endogenous promoter Pdes of Fusarium fujikura.
7. The method according to claim 1, characterized in that The expression of the meglutaryl-CoA reductase catalytic region gene tHMGR is regulated by the terminator Ttef1 derived from Aspergillus nidulans.
8. The method according to claim 1, characterized in that include: The CRISPR-Cas9 gene editing technology was used to replace the original bikaverin encoding genes bik1, bik2, and bik3 on the genome of the starting strain Fusarium fujikuroi CCTCCNO: M2019378 with the meglutaryl-CoA reductase catalytic region gene tHMGR from Yarrowia lipolytica, thereby obtaining a genetically engineered bacterium for producing gibberellin GA3; the expression of the meglutaryl-CoA reductase catalytic region gene tHMGR was regulated by the endogenous promoter Pdes of Fusarium fujikuroi and the terminator Ttef1 from Aspergillus nidulans.
9. A genetically engineered bacterium for producing gibberellin GA3 constructed according to any one of claims 1 to 8.
10. The use of the genetically engineered bacteria as claimed in claim 9 in the fermentation production of gibberellin GA3, characterized in that: The application method is as follows: the Fujikura gibberellosis is inoculated into a fermentation medium, and fermentation is carried out for 150 to 200 hours at 25 to 30° C. and 200 to 300 rpm to obtain gibberellin GA3.
Citation Information
Cited By
Gibberellin high-yielding strain with byproducts eliminated, and construction method and application thereof
CN119530027A
